Jun 20, 2025
Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025
Jun 09, 2025
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes
May 14, 2025
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma
Mar 10, 2025
Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal
Feb 13, 2025
Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025
Feb 05, 2025
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025
Jan 29, 2025
Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
Nov 13, 2024
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update
Nov 11, 2024
Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia
Oct 08, 2024
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit
Sep 16, 2024
Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
Aug 27, 2024
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys
Aug 06, 2024
Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024
Jun 27, 2024
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
Jun 21, 2024
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024
Jun 03, 2024
Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies
Feb 21, 2024
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
Jan 06, 2021
Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer
Jan 04, 2021
Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference
Dec 16, 2020
Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer